STUDIES
KMR’s Clinical Trial Cycle Time program enables companies to assess their clinical trial performance through the examination of core clinical trial process cycle times. Participants rely on this information to make informed decisions with respect to planning and performance improvement. The study presents the performance metrics based on clinical trial process, e.g., data capture, as well as a variety of key factors such as TA, disease area, indication; phase, subject status, and molecule type.